To Patent or Not To Patent: That is the Question

Patents are not our CEO Call Bass' favorite subject. He's not so fond of them. Check out his retweet:

So I did not find it surprising when I got the following email from Senior Public Relations Manager, Rama Dunayevich.

• I wanted to share an article in Nature for which Autodesk Distinguished Research Scientist Andrew Hessel was interviewed a couple weeks back.
• The piece posits that a bridge is being built in the world of synthetic biology between the "patent camp" and the "open-source camp."

Check out her Tweet:

Check out the Nature article and decide for yourself:

• Synthetic biology: Cultural divide

The question of patents is alive in the lab.